COVID-19: From bench to bed side

Diabetes Metab Syndr. 2020 Jul-Aug;14(4):277-281. doi: 10.1016/j.dsx.2020.04.011. Epub 2020 Apr 9.

Abstract

Background and aims: The last two decades have experienced the outbreaks of three different coronaviruses in the different parts of the world namely; Severe acute respiratory syndrome cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and Severe acute respiratory syndrome cornonavirus-2 (SARS-CoV-2). We aimed to delineate the differences in viral dynamics and clinical features between them and tried to focus on every basic details of SARS-COV-2 (COVID-19) that every health care provider must know.

Methods: We systematically searched the PubMed database up till April 2, 2020 and retrieved all the articles published on SARS-CoV-2, SARS-CoV-1, MERS-CoV that dealt with viral dynamics.

Results: Ample data is available to suggest the differences in etiology, transmission cycle, diagnosis, genetics, hosts, reproductive rates, clinical features, laboratory diagnosis and radiological features between SARS-CoV-1, MERS-CoV and SARS-CoV-2.

Conclusion: Although SARS-CoV-2 (COVID-19) is more infectious than SARS-CoV-1 and MERS-CoV, most infections are generally mild and self-limiting. However, case-fatality rates are very high in patients with COVID-19 with comorbidities, compared to SARS-CoV-1 and MERS-CoV.

Keywords: COVID-19; MERS; SARS-Co-V-2; SARS-CoV-1; Viral dynamics.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adult
  • Aged
  • Betacoronavirus / genetics
  • Betacoronavirus / immunology
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • COVID-19 Testing
  • COVID-19 Vaccines
  • Clinical Laboratory Techniques
  • Comorbidity
  • Coronavirus / genetics
  • Coronavirus / pathogenicity
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / prevention & control
  • Coronavirus Infections* / transmission
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pandemics* / prevention & control
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / prevention & control
  • Pneumonia, Viral* / transmission
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome / diagnosis
  • Severe Acute Respiratory Syndrome / transmission
  • Severe acute respiratory syndrome-related coronavirus / genetics
  • Severe acute respiratory syndrome-related coronavirus / pathogenicity
  • Tomography, X-Ray Computed
  • Viral Vaccines

Substances

  • COVID-19 Vaccines
  • Viral Vaccines